Zusammenfassung
Klinisches Erscheinungsbild und Krankheitsverlauf bei Patienten mit lymphatischen Systemerkrankungen weisen eindringlich auf Störungen der Immunantwort hin, die nicht selten auch von großer Bedeutung für die Prognose der Erkrankung sind. Die Definition und Charakterisierung dieser Immundefekte ist seit langem Gegenstand intensiver Forschung der Hämatologie und klinischen Immunologie.
Mit Unterstützung der Deutschen Forschungsgemeinschaft (Ru 215/4-2) und des Tumorzentrums Berlin e.V.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Case DC, Hansen JA, Corrales E, Young CW, Dupont B, Pinsky CM, Good RA (1977) Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin’s disease in continous long remissions. Blood 49: 771–778
De Vita VT (1973) Lymphocyte reactivity in Hodgkins’ disease: a lymphocyte civil war. N Engl J Med 289: 801–802
Eby WC, Chong CA, Dray S, Molinaro GA (1975) Enumerating immunoglobulin-secreting cells among peripheral human lymphocytes. A hemolytic plaque assay for a B cell function. J Immunol 115: 1700–1703
Fauci AS, Pratt KR (1976) Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B-lymphocytes. J Exp Med 144: 674–684
Gronowicz E, Coutinho A, Melchers F (1976) A plaque assay for cells secreting Ig of a given type or class. Eur J Immunol 6: 588–590
Herrmann F, Lochner A, Philippen H, Jauer B, Rühl H (1983) Imbalance of T cell sub-populations in patients with chronic lymphocytic leukemia of the B cell type. Clin exp Immunol 49: 157–162
Herrmann F, Sieber G, Jauer B, Lochner A, Komischke B, Rühl H (1983) Evaluation of the circulating and splenic lymphocyte subpopulations in patients with Non-Hodgkin Lymphomas and Hodgkin’s disease using monoclonal antibodies. Blut 47: 41–51
Hillinger SM, Herzig GP (1978) Impaired cell-mediated immunity in Hodgkin’s disease mediated by suppressor lymphocytes and monocytes. J Clin Invest 60: 1620–1627
Longmire RL, McMillan R, Yelenosky R, Armstrong S, Lang JE, Craddock CG (1973) In vitro splenic IgG synthesis in Hodgkin’s disease. N Engl J Med 289: 763–766
Rühl H, Scholle H, Bochert G, Vogt W (1978) Activation of human lymphocyte subpopulations in patients with chronic lymphocytic leukemia. Z Immunf Immunbiol 154: 75–87
Rühl H, Rühl U, Sieber G (1980) Immune alterations in patients with Hodgkin’s disease. Cell Mol Biol 25: 409–414
Sieber G, Bochert G, Enders B, Rühl H (1980) Characteristics of immunoglobulin secretion in man evaluated by a reverse hemolytic plaque assay. Blut 41: 81–92
Twomey JJ, Laughter AH, Farrow S, Douglas CC (1975) Hodgkin’s disease, an immunodepleting and immunosuppressive disorder. J Clin Invest 56: 467–475
Waldmann TA, Broder S, Krakauer R, MacDermott RP, Durm M, Goldman C, Meade B (1976) The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma. Fed Proc 35: 2067–2072
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin, Heidelberg
About this paper
Cite this paper
Rühl, H., Herrmann, F., Teichmann, H., Ludwig, W.D., Sieber, G. (1985). Störungen der B-Zelldifferenzierung in Vitro bei Patienten mit Lymphatischen Systemerkrankungen. In: Aktuelle Aspekte der Tumor-Immunologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70097-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-70097-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13924-9
Online ISBN: 978-3-642-70097-2
eBook Packages: Springer Book Archive